Johnson & Johnson Q3 Adjusted EPS $2.66 Beats $2.51 Estimate, Sales $21.35B Beat $21.04B Estimate
Portfolio Pulse from Benzinga Newsdesk
Johnson & Johnson (NYSE:JNJ) reported Q3 earnings of $2.66 per share, beating the analyst consensus estimate of $2.51 by 5.98%. This is a 19.28% increase from the same period last year. The company also reported quarterly sales of $21.35 billion, beating the analyst consensus estimate of $21.04 billion by 1.48%. This is a 6.78% increase from the same period last year.
October 17, 2023 | 10:22 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Johnson & Johnson reported better than expected Q3 earnings and sales, which could positively impact its stock price.
Johnson & Johnson's Q3 earnings and sales beat estimates, which is typically a positive signal for the stock price. The company's earnings per share increased by 19.28% and sales increased by 6.78% compared to the same period last year, indicating strong financial performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100